Imaging Technology
JANUARY 23, 2024
milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.
Imaging Technology
JUNE 21, 2023
milla1cf Wed, 06/21/2023 - 19:47 June 21, 2023 — Fresenius Kabi , a leading provider of injectable medicines, announced today it has launched the diagnostic pharmaceutical agent, Sincalide for Injection, an authorized generic for Bracco Diagnostics Inc. ’s supply chain of care," said John Ducker , president and CEO of Fresenius Kabi USA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
APRIL 22, 2024
ASRT President Brandon Smith, MBA If passed, MARCA would ensure complete Medicare reimbursement for services provided by a radiologist assistant, when supervised by a radiologist as part of a radiologist-led patient care team, regardless of the setting in which the service is performed, according to the ASRT.
AuntMinnie
JUNE 3, 2024
"But the model that we have is on the opposite end of the spectrum, where the idea is that the theranostics physicians, whether they're nuclear medicine physicians or radiologists, actually temporarily become the patient's subspecialty medical oncologist," Siegel said. "As led by Harshad Kulkarni, MD, as principal investigator.
AuntMinnie
JUNE 14, 2024
Predicting outcomes, progression The ability to predict treatment outcomes and disease progression is crucial for optimizing patient care and guiding therapeutic decisions. Similarly, in diabetes, non-invasive imaging can assess pancreatic health and monitor for complications, revolutionizing patient care.
Imaging Technology
MARCH 21, 2024
John's leadership was vital to building a successful mission-driven organization committed to increasing access to high-quality, affordable patient care.
Imaging Technology
JULY 5, 2023
Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Such contaminants pose regulatory and waste management challenges for pharmaceutical companies, hospitals, and health systems. Under terms of the agreement, NorthStar will supply its high purity, non-carrier added (n.c.a.) Ac-225 to Nucleus.
Expert insights. Personalized for you.
105 
Let's personalize your content